Search Results

Showing results 81-83 of 83 for 'Cancer treatment'


  • c26_HA800[1].jpg
    EMA Approves Steba’s Prostate Cancer Drug

    The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended by a majority of 29-2 the approval for marketing of the Tookad drug for treatment of prostate cancer developed by Israeli company Steba Biotech. Tookad is a complex treatment, in which the patient takes a drug, but the drug is activated only in the area of the tumor, through the skin. The product, developed by Professor Avigdor Scherz and Dr. Yoram Salomon of the Weizmann Institute of Science, has already been approved for marketing and sale in Israel and Mexico.

    /news-media/in-the-news/ema-approves-steba-s-prostate-cancer-drug
  • lead_960[1].jpg
  • Untitled-23-300x480.jpg